A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
To assess the pharmacokinetic profile and safety of ranolazine PR in healthy Korean and
Caucasian volunteers after oral administration of Ranolazine at the doses of 375, 500, 750mg
after single and repeated oral administrations.